Cargando…

EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells

(-)-epigallocatechin-3-gallate (EGCG) is a well-known cancer chemopreventive agent. The potential mechanisms include regulation of multiple molecules. Carcinogenesis in lung cancer is related to the imbalance of tumor suppressor and oncogene. JWA is a structurally novel microtubule-binding protein a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yuan, Shen, Xin, Wang, Xueming, Li, Aiping, Wang, Pengqi, Jiang, Pan, Zhou, Jianwei, Feng, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457146/ https://www.ncbi.nlm.nih.gov/pubmed/26046674 http://dx.doi.org/10.1038/srep11009

Ejemplares similares

Targeting JWA for Cancer Therapy: Functions, Mechanisms and Drug Discovery
por: Ding, Kun, et al.
Publicado: (2022)

JWA deficiency induces malignant transformation of murine embryonic fibroblast cells
por: Qi, Hong, et al.
Publicado: (2018)

Astrocytic JWA deletion exacerbates dopaminergic neurodegeneration by decreasing glutamate transporters in mice
por: Wang, Rihua, et al.
Publicado: (2018)

JAC4 Protects from X-ray Radiation-Induced Intestinal Injury by JWA-Mediated Anti-Oxidation/Inflammation Signaling
por: Zhou, Yan, et al.
Publicado: (2022)

JWA suppresses the invasion of human breast carcinoma cells by downregulating the expression of CXCR4
por: Xu, Lingyun, et al.
Publicado: (2018)

JAC1 suppresses proliferation of breast cancer through the JWA/p38/SMURF1/HER2 signaling
por: Ren, Yanlin, et al.
Publicado: (2021)

JWA regulates XRCC1 and functions as a novel base excision repair protein in oxidative-stress-induced DNA single-strand breaks
por: Wang, Shouyu, et al.
Publicado: (2009)

JWA Deficiency Suppresses Dimethylbenz[a]Anthracene-Phorbol Ester Induced Skin Papillomas via Inactivation of MAPK Pathway in Mice
por: Gong, Zhenghua, et al.
Publicado: (2012)

JAC1 targets YY1 mediated JWA/p38 MAPK signaling to inhibit proliferation and induce apoptosis in TNBC
por: Zhai, Zurong, et al.
Publicado: (2022)

JWA suppresses proliferation in trastuzumab-resistant breast cancer by downregulating CDK12
por: Liang, Yan, et al.
Publicado: (2021)

JWA loss promotes cell migration and cytoskeletal rearrangement by affecting HER2 expression and identifies a high-risk subgroup of HER2-positive gastric carcinoma patients
por: Qian, Jing, et al.
Publicado: (2016)

JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis
por: Ding, Kun, et al.
Publicado: (2023)

Synergistic Role between p53 and JWA: Prognostic and Predictive Biomarkers in Gastric Cancer
por: Liu, Xin, et al.
Publicado: (2012)

Ciprofloxacin is a potential topoisomerase II inhibitor for the treatment of NSCLC
por: KLOSKOWSKI, TOMASZ, et al.
Publicado: (2012)

JWA down-regulates HER2 expression via c-Cbl and induces lapatinib resistance in human gastric cancer cells
por: Ma, Ling, et al.
Publicado: (2016)

An EGCG Derivative in Combination with Nimotuzumab for the Treatment of Wild-Type EGFR NSCLC
por: Huang, Yanping, et al.
Publicado: (2023)

EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
por: Wang, Xuemin, et al.
Publicado: (2015)

ING4 regulates JWA in angiogenesis and their prognostic value in melanoma patients
por: Lu, J, et al.
Publicado: (2013)

JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells
por: Xu, W, et al.
Publicado: (2014)

Correction: EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer
por: Wang, Xuemin, et al.
Publicado: (2015)

Dynamics of human DNA topoisomerases IIα and IIβ in living cells
por: Christensen, Morten O., et al.
Publicado: (2002)

Jwá'n ngwan-keéh reéh xa'gox = creencias de nuestros antepasados
por: Cruz Santiago, Emiliano
Publicado: (2010)

DNA topoisomerase IIα and Ki67 are prognostic factors in patients with hepatocellular carcinoma
por: Cao, Yi, et al.
Publicado: (2017)

Enhanced Topoisomerase I Activity and Increased Topoisomerase IIα Content in Cisplatin‐resistant Cancer Cell Lines
por: Minagawa, Yukihisa, et al.
Publicado: (1997)

Roles of the C-terminal domains of topoisomerase IIα and topoisomerase IIβ in regulation of the decatenation checkpoint
por: Kozuki, Toshiyuki, et al.
Publicado: (2017)

Jwa participates the maintenance of intestinal epithelial homeostasis via ERK/FBXW7-mediated NOTCH1/PPARγ/STAT5 axis and acts as a novel putative aging related gene
por: Li, Xiong, et al.
Publicado: (2022)

Effects of JWA, XRCC1 and BRCA1 mRNA expression on molecular staging for personalized therapy in patients with advanced esophageal squamous cell carcinoma
por: Wei, Bin, et al.
Publicado: (2015)

Differential Expression of DNA Topoisomerase IIα and IIβ Genes between Small Cell and Non‐small Cell Lung Cancer
por: Syahruddin, Elisna, et al.
Publicado: (1998)

Natural Products as Topoisomerase II Poisons: Effects of Thymoquinone on DNA Cleavage Mediated by Human Topoisomerase IIα
por: Ashley, Rachel E., et al.
Publicado: (2014)

The α isoform of topoisomerase II is required for hypercompaction of mitotic chromosomes in human cells
por: Farr, Christine J., et al.
Publicado: (2014)

JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells
por: Wang, Q, et al.
Publicado: (2017)

EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC
por: Meng, Jiao, et al.
Publicado: (2019)

Genistein Inhibition of Topoisomerase IIα Expression Participated by Sp1 and Sp3 in HeLa Cell
por: Zhou, Najing, et al.
Publicado: (2009)

Precursor-Directed Generation of Indolocarbazoles with Topoisomerase IIα Inhibitory Activity
por: Wang, Cong, et al.
Publicado: (2018)

Complex of EGCG with Cu(II) Suppresses Amyloid Aggregation and Cu(II)-Induced Cytotoxicity of α-Synuclein
por: Teng, Yilong, et al.
Publicado: (2019)

Cytoprotective Effect of Epigallocatechin Gallate (EGCG)-5′-O-α-Glucopyranoside, a Novel EGCG Derivative
por: Han, Sang Yun, et al.
Publicado: (2018)

Suppressive Effects of EGCG on Cervical Cancer
por: Wang, Ying-Qi, et al.
Publicado: (2018)

Expression of DNA topoisomerase II-α: Clinical significance in laryngeal carcinoma
por: FENG, YAN, et al.
Publicado: (2014)

Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase II α gene transfer is independent of topoisomerase II β
por: Zhou, Z, et al.
Publicado: (2001)

Topoisomerase IIα Binding Domains of Adenomatous Polyposis Coli Influence Cell Cycle Progression and Aneuploidy
por: Wang, Yang, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tlholikru4noipfm9r5shi29qa